Report Detail
Global Long Acting Drug Delivery Market Insights, Forecast to 2028
- RnM4416729 |
- 01 April, 2022 |
- Global |
- 108 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global Long Acting Drug Delivery Market
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The global Long Acting Drug Delivery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Device accounting for % of the Long Acting Drug Delivery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Long Acting Drug Delivery market size is valued at US$ million in 2021, while the North America and Europe Long Acting Drug Delivery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Long Acting Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long Acting Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long Acting Drug Delivery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long Acting Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long Acting Drug Delivery market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Long Acting Drug Delivery market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Long Acting Drug Delivery Breakdown Data by Type
Device
Parenteral Injections
Long Acting Drug Delivery Breakdown Data by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Frequently Asked Questions
What factors will challenge the Long Acting Drug Delivery market growth?
Which end-use segment will expand at the fastest CAGR in the Long Acting Drug Delivery market?
Which are the emerging players in the Long Acting Drug Delivery market?
How concentrated is the Long Acting Drug Delivery market?
Which factors are positively contributing to the Long Acting Drug Delivery market growth?
Which are the novel product innovations in the Long Acting Drug Delivery market?
Which product segment will emerge as the most lucrative in the Long Acting Drug Delivery market?
Which factors are increasing the competition in the Long Acting Drug Delivery market?
Which are the strategic measures taken by the Long Acting Drug Delivery industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Long Acting Drug Delivery market in the coming years?
Table of Contents
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Device
- 1.2.3 Parenteral Injections
- 1.3 Market by Application
- 1.3.1 Global Long Acting Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospital
- 1.3.3 Specialty Clinics
- 1.3.4 Clinical Research Institutes
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)
- 2.2 Long Acting Drug Delivery Growth Trends by Region
- 2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)
- 2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)
- 2.3 Long Acting Drug Delivery Market Dynamics
- 2.3.1 Long Acting Drug Delivery Industry Trends
- 2.3.2 Long Acting Drug Delivery Market Drivers
- 2.3.3 Long Acting Drug Delivery Market Challenges
- 2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Long Acting Drug Delivery Players by Revenue
- 3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)
- 3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)
- 3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
- 3.4 Global Long Acting Drug Delivery Market Concentration Ratio
- 3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021
- 3.5 Long Acting Drug Delivery Key Players Head office and Area Served
- 3.6 Key Players Long Acting Drug Delivery Product Solution and Service
- 3.7 Date of Enter into Long Acting Drug Delivery Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
- 4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)
- 4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Long Acting Drug Delivery Breakdown Data by Application
- 5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)
- 5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Long Acting Drug Delivery Market Size (2017-2028)
- 6.2 North America Long Acting Drug Delivery Market Size by Type
- 6.2.1 North America Long Acting Drug Delivery Market Size by Type (2017-2022)
- 6.2.2 North America Long Acting Drug Delivery Market Size by Type (2023-2028)
- 6.2.3 North America Long Acting Drug Delivery Market Share by Type (2017-2028)
- 6.3 North America Long Acting Drug Delivery Market Size by Application
- 6.3.1 North America Long Acting Drug Delivery Market Size by Application (2017-2022)
- 6.3.2 North America Long Acting Drug Delivery Market Size by Application (2023-2028)
- 6.3.3 North America Long Acting Drug Delivery Market Share by Application (2017-2028)
- 6.4 North America Long Acting Drug Delivery Market Size by Country
- 6.4.1 North America Long Acting Drug Delivery Market Size by Country (2017-2022)
- 6.4.2 North America Long Acting Drug Delivery Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)
- 7.2 Europe Long Acting Drug Delivery Market Size by Type
- 7.2.1 Europe Long Acting Drug Delivery Market Size by Type (2017-2022)
- 7.2.2 Europe Long Acting Drug Delivery Market Size by Type (2023-2028)
- 7.2.3 Europe Long Acting Drug Delivery Market Share by Type (2017-2028)
- 7.3 Europe Long Acting Drug Delivery Market Size by Application
- 7.3.1 Europe Long Acting Drug Delivery Market Size by Application (2017-2022)
- 7.3.2 Europe Long Acting Drug Delivery Market Size by Application (2023-2028)
- 7.3.3 Europe Long Acting Drug Delivery Market Share by Application (2017-2028)
- 7.4 Europe Long Acting Drug Delivery Market Size by Country
- 7.4.1 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)
- 7.4.2 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)
- 8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type
- 8.2.1 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Long Acting Drug Delivery Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Application
- 8.3.1 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Long Acting Drug Delivery Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Long Acting Drug Delivery Market Size by Region
- 8.4.1 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)
- 9.2 Latin America Long Acting Drug Delivery Market Size by Type
- 9.2.1 Latin America Long Acting Drug Delivery Market Size by Type (2017-2022)
- 9.2.2 Latin America Long Acting Drug Delivery Market Size by Type (2023-2028)
- 9.2.3 Latin America Long Acting Drug Delivery Market Share by Type (2017-2028)
- 9.3 Latin America Long Acting Drug Delivery Market Size by Application
- 9.3.1 Latin America Long Acting Drug Delivery Market Size by Application (2017-2022)
- 9.3.2 Latin America Long Acting Drug Delivery Market Size by Application (2023-2028)
- 9.3.3 Latin America Long Acting Drug Delivery Market Share by Application (2017-2028)
- 9.4 Latin America Long Acting Drug Delivery Market Size by Country
- 9.4.1 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)
- 9.4.2 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)
- 10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type
- 10.2.1 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Long Acting Drug Delivery Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Application
- 10.3.1 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Long Acting Drug Delivery Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Long Acting Drug Delivery Market Size by Country
- 10.4.1 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 ViiV Healthcare
- 11.1.1 ViiV Healthcare Company Details
- 11.1.2 ViiV Healthcare Business Overview
- 11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
- 11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.1.5 ViiV Healthcare Recent Developments
- 11.2 Halozyme Therapeutics
- 11.2.1 Halozyme Therapeutics Company Details
- 11.2.2 Halozyme Therapeutics Business Overview
- 11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
- 11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.2.5 Halozyme Therapeutics Recent Developments
- 11.3 Lubrizol Life Science
- 11.3.1 Lubrizol Life Science Company Details
- 11.3.2 Lubrizol Life Science Business Overview
- 11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
- 11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.3.5 Lubrizol Life Science Recent Developments
- 11.4 Celanese Corporation
- 11.4.1 Celanese Corporation Company Details
- 11.4.2 Celanese Corporation Business Overview
- 11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
- 11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.4.5 Celanese Corporation Recent Developments
- 11.5 Kashiv BioSciences
- 11.5.1 Kashiv BioSciences Company Details
- 11.5.2 Kashiv BioSciences Business Overview
- 11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
- 11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.5.5 Kashiv BioSciences Recent Developments
- 11.6 4P Therapeutics
- 11.6.1 4P Therapeutics Company Details
- 11.6.2 4P Therapeutics Business Overview
- 11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
- 11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.6.5 4P Therapeutics Recent Developments
- 11.7 Ipsen
- 11.7.1 Ipsen Company Details
- 11.7.2 Ipsen Business Overview
- 11.7.3 Ipsen Long Acting Drug Delivery Introduction
- 11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.7.5 Ipsen Recent Developments
- 11.8 Midatech Pharma
- 11.8.1 Midatech Pharma Company Details
- 11.8.2 Midatech Pharma Business Overview
- 11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
- 11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.8.5 Midatech Pharma Recent Developments
- 11.9 Re-Vana Therapeutics
- 11.9.1 Re-Vana Therapeutics Company Details
- 11.9.2 Re-Vana Therapeutics Business Overview
- 11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
- 11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.9.5 Re-Vana Therapeutics Recent Developments
- 11.10 Creative Biolabs
- 11.10.1 Creative Biolabs Company Details
- 11.10.2 Creative Biolabs Business Overview
- 11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
- 11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)
- 11.10.5 Creative Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Long Acting Drug Delivery. Industry analysis & Market Report on Long Acting Drug Delivery is a syndicated market report, published as Global Long Acting Drug Delivery Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Long Acting Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
